Currently, there have been reports of in vitro inhibition of RCC cell lines (786-O) by TOFA, an inhibitor of ACC, which was speculated to be related to the inhibition of the PI3K/Akt/mTOR pathway (68). This evidence concerns the gene AKT1 and renal cell carcinoma.